Vanda Pharmaceuticals Inc. (VNDA) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -50.22M | -29.42M | -31.63M | -15.25M | -33.15M | -1.82M | -14.58M | -6.93M | 7.57M | -3.73M | -2.05M | -13.22M |
| Operating CF Margin % | -97.1% | -51.41% | -56.22% | -29% | -66.24% | -3.42% | -30.6% | -13.73% | 15.95% | -8.24% | -5.28% | -28.7% |
| Operating CF Growth % | -51.5% | -1518.99% | -116.9% | -120.15% | -537.93% | 51.31% | -611.27% | 47.59% | -76.2% | -139.63% | -115.97% | -332.54% |
| Net Income | -48.57M | -141.19M | -22.59M | -27.21M | -29.49M | -4.91M | -5.32M | -4.52M | -4.15M | -2.4M | 137K | 1.52M |
| Depreciation & Amortization | 3.53M | 5.86M | 2.05M | -2.79M | 1.98M | 1.97M | 1.97M | 1.97M | 2.22M | 1.16M | 580K | 602K |
| Stock-Based Compensation | 0 | 2.29M | 2.11M | 2.11M | 2.97M | 2.86M | 3M | 2.99M | 3.58M | 3.27M | 3.17M | 3.25M |
| Deferred Taxes | 0 | 103.19M | -5.97M | -7.97M | -7.8M | -1.91M | -3.09M | -1.23M | -246K | -7.48M | 2.73M | 1.46M |
| Other Non-Cash Items | 2.71M | -2.59M | 895K | 5.29M | 1.1M | -545K | -1.49M | -1.52M | -825K | -1.1M | -1.88M | -1.22M |
| Working Capital Changes | -7.88M | 3.03M | -8.13M | 15.32M | -1.91M | 718K | -9.64M | -4.61M | 6.98M | 2.82M | -6.78M | -18.83M |
| Change in Receivables | -2.33M | -4.08M | -5.57M | -353K | 2.53M | -4.43M | -830K | -5.16M | -2.59M | -4.84M | 4.33M | -9.1M |
| Change in Inventory | 294K | -1.28M | 32K | -368K | -1.85M | -107K | -214K | 263K | 29K | -427K | -554K | 136K |
| Change in Payables | 1.48M | 9.08M | -10.22M | 11.33M | 5.64M | -2.13M | 0 | 0 | 1.17M | 3.33M | -280K | -3.24M |
| Cash from Investing | 20.23M | 44.87M | 21.36M | -15.27M | 43.9M | 3.99M | 12.06M | -15.26M | -18.22M | -43.78M | 35.33M | -190.89M |
| Capital Expenditures | -221K | -102K | -161K | -299K | -436K | -214K | -161K | -108K | -7K | -253K | -24K | -55K |
| CapEx % of Revenue | 0.43% | 0.18% | 0.29% | 0.57% | 0.87% | 0.4% | 0.34% | 0.21% | 0.01% | 0.56% | 0.06% | 0.12% |
| Acquisitions | -10M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.71M | 0 | -35.35M | 190.84M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.52M | 0 | -100.67M | 35.35M | -190.84M |
| Cash from Financing | -776K | -640K | -517K | -425K | -1.32M | -155K | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt Issued (Net) | -776K | -640K | -517K | -425K | -409K | -155K | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | -915K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -30.92M | 14.93M | -10.96M | -30.81M | 9.48M | 1.82M | -2.46M | -22.2M | -10.66M | -47.37M | 33.16M | -204.14M |
| Free Cash Flow | -50.44M | -29.52M | -31.79M | -15.55M | -33.58M | -2.03M | -14.74M | -7.04M | 7.56M | -3.98M | -2.07M | -13.28M |
| FCF Margin % | -97.53% | -51.59% | -56.5% | -29.57% | -67.11% | -3.82% | -30.94% | -13.94% | 15.93% | -8.8% | -5.34% | -28.82% |
| FCF Growth % | -50.19% | -1353.42% | -115.62% | -121.02% | -544.1% | 49.03% | -610.8% | 47% | -76.18% | -143.54% | -116.34% | -341.72% |
| FCF per Share | -0.85 | -0.50 | -0.54 | -0.26 | -0.57 | -0.03 | -0.25 | -0.12 | 0.13 | -0.07 | -0.04 | -0.23 |
| FCF Conversion (FCF/Net Income) | 1.03x | 0.21x | 1.40x | 0.56x | 1.12x | 0.37x | 2.74x | 1.53x | -1.83x | 1.56x | -14.96x | -8.70x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |